Reviva Pharmaceuticals Holdings Inc. (RVPH) — Financial Flexibility Index
Reviva Pharmaceuticals Holdings Inc. (RVPH) has a Financial Flexibility Index of -1.00x as of June 2026. Free cash flow of $-5.92 Trillion (operating CF $-5.92 Trillion minus capex $0.00) represents -1% of total liabilities ($5.93 Trillion). Check cash flow reinvestment rate of Reviva Pharmaceuticals Holdings Inc. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Reviva Pharmaceuticals Holdings Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Reviva Pharmaceuticals Holdings Inc. across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Reviva Pharmaceuticals Holdings Inc..
Annual Financial Flexibility Index for Reviva Pharmaceuticals Holdings Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Reviva Pharmaceuticals Holdings Inc.. Explore Reviva Pharmaceuticals Holdings Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.38x | $-24.59 Million | $-24.59 Million | $7.28 Million | ▼ -48.0% |
| 2024 | -2.28x | $-33.54 Million | $-33.54 Million | $14.69 Million | ▼ -45.0% |
| 2023 | -1.58x | $-28.32 Million | $-28.32 Million | $17.98 Million | ▲ +12.5% |
| 2022 | -1.80x | $-18.96 Million | $-18.96 Million | $10.53 Million | ▲ +54.1% |
| 2021 | -3.93x | $-10.67 Million | $-10.67 Million | $2.72 Million | ▼ -218.2% |
| 2020 | -1.23x | $-4.07 Million | $-4.07 Million | $3.30 Million | ▼ -3748.1% |
| 2019 | -0.03x | $-218.44K | $-218.44K | $6.81 Million | ▲ +81.8% |
| 2018 | -0.18x | $-1.07 Million | $-1.07 Million | $6.09 Million | — |